- call +1-201-465-4211
- email sales@mrinsights.biz
Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Testing detects substances not normally found in the body, with the exception of some hormones and steroids measured as part of sports testing.
Scope of the Report:
This report studies the Drug Abuse Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Drug Abuse Testing market by product type and applications/end industries.
Illegal drug is non-prescribed type of drug taken for non-medicinal reasons that affects physical and mental health of addicts. There were more than 208 million people consuming illegal drugs worldwide. Change in life style attracts younger people to consume illicit drugs, which is a major driver for this market.Therefore, it is indispensable to screen for drug abuse, to monitor someone with a substance abuse problem, to monitor compliance with prescribed medications, or to detect and evaluate drug intoxication or overdose
The global Drug Abuse Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Drug Abuse Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Biomedical Diagnostics
BioMerieux
Abbott
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Beckman Coulter
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Employment testing
Random testing
Reasonable testing
Post accident testing
Follow-up testing
Market Segment by Applications, can be divided into
Schools and educational institutes
Hospitals and healthcare units
Government and private departments
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Drug Abuse Testing Market Overview
1.1 Product Overview and Scope of Drug Abuse Testing
1.2 Classification of Drug Abuse Testing by Types
1.2.1 Global Drug Abuse Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Drug Abuse Testing Revenue Market Share by Types in 2017
1.2.3 Employment testing
1.2.4 Random testing
1.2.5 Reasonable testing
1.2.6 Post accident testing
1.2.7 Follow-up testing
1.3 Global Drug Abuse Testing Market by Application
1.3.1 Global Drug Abuse Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Schools and educational institutes
1.3.3 Hospitals and healthcare units
1.3.4 Government and private departments
1.4 Global Drug Abuse Testing Market by Regions
1.4.1 Global Drug Abuse Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Drug Abuse Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Drug Abuse Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Abuse Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Drug Abuse Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Abuse Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Drug Abuse Testing (2013-2023)
2 Manufacturers Profiles
2.1 Biomedical Diagnostics
2.1.1 Business Overview
2.1.2 Drug Abuse Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Biomedical Diagnostics Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 BioMerieux
2.2.1 Business Overview
2.2.2 Drug Abuse Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BioMerieux Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Drug Abuse Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bio-Rad
2.4.1 Business Overview
2.4.2 Drug Abuse Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bio-Rad Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Dako
2.5.1 Business Overview
2.5.2 Drug Abuse Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dako Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 DiaSorin
2.6.1 Business Overview
2.6.2 Drug Abuse Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 DiaSorin Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eiken
2.7.1 Business Overview
2.7.2 Drug Abuse Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eiken Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Fujirebio
2.8.1 Business Overview
2.8.2 Drug Abuse Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Fujirebio Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Beckman Coulter
2.9.1 Business Overview
2.9.2 Drug Abuse Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Beckman Coulter Drug Abuse Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Drug Abuse Testing Market Competition, by Players
3.1 Global Drug Abuse Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug Abuse Testing Players Market Share
3.2.2 Top 10 Drug Abuse Testing Players Market Share
3.3 Market Competition Trend
4 Global Drug Abuse Testing Market Size by Regions
4.1 Global Drug Abuse Testing Revenue and Market Share by Regions
4.2 North America Drug Abuse Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Drug Abuse Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Drug Abuse Testing Revenue and Growth Rate (2013-2018)
4.5 South America Drug Abuse Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Drug Abuse Testing Revenue and Growth Rate (2013-2018)
5 North America Drug Abuse Testing Revenue by Countries
5.1 North America Drug Abuse Testing Revenue by Countries (2013-2018)
5.2 USA Drug Abuse Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Drug Abuse Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Drug Abuse Testing Revenue and Growth Rate (2013-2018)
6 Europe Drug Abuse Testing Revenue by Countries
6.1 Europe Drug Abuse Testing Revenue by Countries (2013-2018)
6.2 Germany Drug Abuse Testing Revenue and Growth Rate (2013-2018)
6.3 UK Drug Abuse Testing Revenue and Growth Rate (2013-2018)
6.4 France Drug Abuse Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Drug Abuse Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Drug Abuse Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Drug Abuse Testing Revenue by Countries
7.1 Asia-Pacific Drug Abuse Testing Revenue by Countries (2013-2018)
7.2 China Drug Abuse Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Drug Abuse Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Drug Abuse Testing Revenue and Growth Rate (2013-2018)
7.5 India Drug Abuse Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Drug Abuse Testing Revenue and Growth Rate (2013-2018)
8 South America Drug Abuse Testing Revenue by Countries
8.1 South America Drug Abuse Testing Revenue by Countries (2013-2018)
8.2 Brazil Drug Abuse Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Drug Abuse Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Drug Abuse Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Drug Abuse Testing by Countries
9.1 Middle East and Africa Drug Abuse Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Drug Abuse Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Drug Abuse Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Drug Abuse Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Drug Abuse Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Drug Abuse Testing Revenue and Growth Rate (2013-2018)
10 Global Drug Abuse Testing Market Segment by Type
10.1 Global Drug Abuse Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Drug Abuse Testing Market Forecast by Type (2018-2023)
10.3 Employment testing Revenue Growth Rate (2013-2023)
10.4 Random testing Revenue Growth Rate (2013-2023)
10.5 Reasonable testing Revenue Growth Rate (2013-2023)
10.6 Post accident testing Revenue Growth Rate (2013-2023)
10.7 Follow-up testing Revenue Growth Rate (2013-2023)
11 Global Drug Abuse Testing Market Segment by Application
11.1 Global Drug Abuse Testing Revenue Market Share by Application (2013-2018)
11.2 Drug Abuse Testing Market Forecast by Application (2018-2023)
11.3 Schools and educational institutes Revenue Growth (2013-2018)
11.4 Hospitals and healthcare units Revenue Growth (2013-2018)
11.5 Government and private departments Revenue Growth (2013-2018)
12 Global Drug Abuse Testing Market Size Forecast (2018-2023)
12.1 Global Drug Abuse Testing Market Size Forecast (2018-2023)
12.2 Global Drug Abuse Testing Market Forecast by Regions (2018-2023)
12.3 North America Drug Abuse Testing Revenue Market Forecast (2018-2023)
12.4 Europe Drug Abuse Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Drug Abuse Testing Revenue Market Forecast (2018-2023)
12.6 South America Drug Abuse Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Drug Abuse Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Drug Abuse Testing Picture
Table Product Specifications of Drug Abuse Testing
Table Global Drug Abuse Testing and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
